Eliminating hepatitis C transmission by enhancing hepatitis C care and treatment in primary health care settings. [ 2016 - 2021 ]

Research Grant

Researchers: Prof Margaret Hellard (Principal investigator) ,  A/Pr Dennis Petrie ,  A/Pr Mark Stoove ,  Dr Joseph Doyle ,  Dr Peter Higgs
View all 10 related researchers

Brief description In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.

Funding Amount $AUD 1,248,704.90

Funding Scheme Partnerships

Notes Partnership Project for Better Health